Patents by Inventor Paul Beckett

Paul Beckett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Apilimod compositions and methods for using same
    Patent number: 11266654
    Abstract: The present invention relates to methods for treating cancer with apilimod and related compositions and methods.
    Type: Grant
    Filed: December 27, 2019
    Date of Patent: March 8, 2022
    Assignee: AI Therapeutics, Inc.
    Inventors: Henri Lichenstein, Jonathan M. Rothberg, Sophia Gayle, Neil Beeharry, Paul Beckett, Sean Landrette, Chris Conrad, Matt Dyer, Tian Xu
  • Apilimod compositions and methods for using same in the treatment of renal cancer
    Patent number: 11166944
    Abstract: The present disclosure relates to methods for treating renal cancer with apilimod and related compositions and methods.
    Type: Grant
    Filed: November 26, 2019
    Date of Patent: November 9, 2021
    Assignee: AI Therapeutics, Inc.
    Inventors: Neil Beeharry, Sophia Gayle, Sean Landrette, Paul Beckett, Chris Conrad, Tian Xu, Jonathan M. Rothberg, Henri Lichenstein
  • ANTI-VIRAL COMPOSITIONS CONTAINING PIKFYVE INHIBITORS AND USE THEREOF
    Publication number: 20200360397
    Abstract: The present invention relates to compositions containing a PIKfyve inhibitor, preferably apilimod, APY0201 or YM-201636, most preferably apilimod, for use in treating or preventing viral infections, preferably Ebola or Marburg virus infections. It also relates to a pharmaceutical pack or kit comprising apilimod and at least one additional anti-viral agent.
    Type: Application
    Filed: July 1, 2020
    Publication date: November 19, 2020
    Inventors: Henri Lichenstein, Jonathan M. Rothberg, Neil Beeharry, Paul Beckett, Sean Landrette, Chris Conrad
  • APILIMOD COMPOSITIONS AND METHODS FOR USING SAME IN THE TREATMENT OF RENAL CANCER
    Publication number: 20200297706
    Abstract: The present disclosure relates to methods for treating renal cancer with apilimod and related compositions and methods.
    Type: Application
    Filed: November 26, 2019
    Publication date: September 24, 2020
    Inventors: Neil Beeharry, Sophia Gayle, Sean Landrette, Paul Beckett, Chris Conrad, Tian Xu, Jonathan M. Rothberg, Henri Lichenstein
  • Apilimod for use in the treatment of melanoma
    Patent number: 10765682
    Abstract: The present invention relates to methods for treating melanoma with apilimod and related compositions and methods.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: September 8, 2020
    Assignee: AI Therapeutics, Inc.
    Inventors: Neil Beeharry, Sophia Gayle, Sean Landrette, Paul Beckett, Chris Conrad, Tian Xu, Jonathan M. Rothberg, Henri Lichenstein
  • APILIMOD COMPOSITIONS AND METHODS FOR USING SAME
    Publication number: 20200268764
    Abstract: The present invention relates to methods for treating cancer with apilimod and related compositions and methods.
    Type: Application
    Filed: December 27, 2019
    Publication date: August 27, 2020
    Inventors: Henri Lichenstein, Jonathan M. Rothberg, Sophia Gayle, Neil Beeharry, Paul Beckett, Sean Landrette, Chris Conrad, Matt Dyer, Tian Xu
  • TOPICAL RAPAMYCIN FORMULATIONS AND THEIR USE IN TREATING FACIAL ANGIOFIBROMAS AND OTHER SKIN DISORDERS
    Publication number: 20200261427
    Abstract: The present disclosure provides gel compositions of rapamycin for topical administration and related compositions and methods including their use in the treatment of a skin condition, disease or disorder.
    Type: Application
    Filed: February 19, 2020
    Publication date: August 20, 2020
    Inventors: Henri Lichenstein, Jonathan M. Rothberg, Tian Xu, Jeff Grotzke, Paul Beckett, Keith Fandrick
  • Anti-viral compositions containing PIKfyve inhibitors and use thereof
    Patent number: 10729694
    Abstract: The present invention relates to compositions containing a PIKfyve inhibitor, preferably apilimod, APY0201 or YM-201636, most preferably apilimod, for use in treating or preventing viral infections, preferably Ebola or Marburg virus infections. It also relates to a pharmaceutical pack or kit comprising apillimod and at least one additional anti-viral agent.
    Type: Grant
    Filed: January 21, 2016
    Date of Patent: August 4, 2020
    Assignee: AI Therapeutics, Inc.
    Inventors: Henri Lichenstein, Jonathan M. Rothberg, Neil Beeharry, Paul Beckett, Sean Landrette, Chris Conrad
  • Methods for treating cancer using apilimod
    Patent number: 10350213
    Abstract: The present invention relates to methods for treating cancer with apilimod and related compositions and methods.
    Type: Grant
    Filed: July 19, 2016
    Date of Patent: July 16, 2019
    Assignee: AI Therapeutics, Inc.
    Inventors: Henri Lichenstein, Jonathan M. Rothberg, Sophia Gayle, Neil Beeharry, Paul Beckett, Sean Landrette, Chris Conrad, Tian Xu
  • APILIMOD FOR USE IN THE TREATMENT OF COLORECTAL CANCER
    Publication number: 20190209576
    Abstract: The present invention relates to methods for treating colorectal cancer with apilimod and related compositions and methods.
    Type: Application
    Filed: November 6, 2015
    Publication date: July 11, 2019
    Inventors: Neil BEEHARRY, Sophia GAYLE, Sean LANDRETTE, Paul BECKETT, Chris CONRAD, Tian XU, Marylens HERNANDEZ, Jonathan M. ROTHBERG, Henri LICHENSTEIN
  • APILIMOD FOR USE IN THE TREATMENT OF RENAL CANCER
    Publication number: 20190201385
    Abstract: The present disclosure relates to methods for treating renal cancer with apilimod and related compositions and methods.
    Type: Application
    Filed: December 19, 2018
    Publication date: July 4, 2019
    Inventors: Neil Beeharry, Sophia Gayle, Sean Landrette, Paul Beckett, Chris Conrad, Tian Xu, Jonathan M. Rothberg, Henri Lichenstein
  • Apilimod Compositions and Methods for Using Same
    Publication number: 20190183902
    Abstract: The present invention relates to methods for treating cancer with apilimod and related compositions and methods.
    Type: Application
    Filed: November 16, 2018
    Publication date: June 20, 2019
    Inventors: Henri Lichenstein, Jonathan M. Rothberg, Sophia Gayle, Neil Beeharry, Paul Beckett, Sean Landrette, Chris Conrad, Matt Dyer, Tian Xu
  • Apilimod for use in the treatment of renal cancer
    Patent number: 10206910
    Abstract: The present disclosure relates to methods for treating renal cancer with apilimod and related compositions and methods.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: February 19, 2019
    Assignee: LAM Therapeutics, Inc.
    Inventors: Neil Beeharry, Sophia Gayle, Sean Landrette, Paul Beckett, Chris Conrad, Tian Xu, Jonathan M. Rothberg, Henri Lichenstein
  • Biomarkers for Treating Cancer with Apilimod
    Publication number: 20190015421
    Abstract: The present disclosure relates to compositions and methods for treating cancer in a subject having cancer cells over-expressing a microphthalmia (MiT) transcription factor with apilimod and related compositions and methods.
    Type: Application
    Filed: January 20, 2017
    Publication date: January 17, 2019
    Inventors: Sophia Gayle, Neil Beeharry, Sean Landrette, Chris Conrad, Paul Beckett, Marylens Hernandez, Tian Xu, Jonathan M. Rothberg, Henri Lichenstein
  • Apilimod compositions and methods for using same
    Patent number: 10179135
    Abstract: The present invention relates to methods for treating cancer with apilimod and related compositions and methods.
    Type: Grant
    Filed: January 23, 2015
    Date of Patent: January 15, 2019
    Assignee: LAM Therapeutics, Inc.
    Inventors: Henri Lichenstein, Jonathan M. Rothberg, Sophia Gayle, Neil Beeharry, Paul Beckett, Sean Landrette, Chris Conrad, Matt Dyer, Tian Xu
  • Inhibitors of arginase and their therapeutic applications
    Patent number: 9994594
    Abstract: Compounds according to Formula I and Formula II are potent inhibitors of Arginase I and II activity: where R1, R2, R3, R4, R5, R6, R7, R8, R9, D, M, X, and Y are defined as set forth in the specification. The invention also provides pharmaceutical compositions of the compounds and methods of their use for treating or preventing a disease or a condition associated with arginase activity.
    Type: Grant
    Filed: August 28, 2014
    Date of Patent: June 12, 2018
    Assignee: Mars, Incorporated
    Inventors: Michael Van Zandt, Adam Golebiowski, Min Koo Ji, Darren Whitehouse, Todd Ryder, Raymond Paul Beckett
  • ACTIVE METABOLITES OF APILIMOD AND USES THEREOF
    Publication number: 20180078561
    Abstract: The present invention relates to compositions comprising one or more active metabolites of apilimod and methods for their use in treating cancer.
    Type: Application
    Filed: January 21, 2016
    Publication date: March 22, 2018
    Inventors: Paul Beckett, Neil Beeharry, Sean Landrette, Chris Conrad, Jonathan M. Rothberg, Henri Lichenstein
  • ANTI-VIRAL COMPOSITIONS CONTAINING PIKFYVE INHIBITORS AND USE THEREOF
    Publication number: 20180028540
    Abstract: The present invention relates to compositions containing a PIKfyve inhibitor, preferably apilimod, APY0201 or YM-201636, most preferably apilimod, for use in treating or preventing viral infections, preferably Ebola or Marburg virus infections. It also relates to a pharmaceutical pack or kit comprising apillimod and at least one additional anti-viral agent.
    Type: Application
    Filed: January 21, 2016
    Publication date: February 1, 2018
    Inventors: Henri LICHENSTEIN, Jonathan M. ROTHBERG, Neil BEEHARRY, Paul BECKETT, Sean LANDRETTE, Chris CONRAD
  • APILIMOD FOR USE IN THE TREATMENT OF MELANOMA
    Publication number: 20170333439
    Abstract: The present invention relates to methods for treating melanoma with apilimod and related compositions and methods.
    Type: Application
    Filed: November 6, 2015
    Publication date: November 23, 2017
    Inventors: Neil BEEHARRY, Sophia GAYLE, Sean LANDRETTE, Paul BECKETT, Chris CONRAD, Tian XU, Jonathan M. ROTHBERG, Henri LICHENSTEIN
  • Vehicle seat
    Patent number: D991687
    Type: Grant
    Filed: November 11, 2021
    Date of Patent: July 11, 2023
    Assignee: Jaguar Land Rover Limited
    Inventors: Stefano Manini, David Brisbourne, Paul Beckett